BERYL DRUGS LTD.

BSE

Performance

Today's Low		Today's High
35.51		37.07

52 Week Low		52 Week High
19.35 (13-Nov-2023)		45.00 (09-Sep-2024)

Open: 37.05

Previous Close: 37.05

Volume: -

Total Traded value: -

Upper circuit: 23.93

Lower circuit: 23.01

Market Depth

Buy Order Quantity		Sell Order Quantity
0		0

Bid Price	Quantity
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
Total:	--

Ask Price	Quantity
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
Total:	--

Fundamentals

Market Cap:	₹11.84 Cr
PE Ratio (TTM):	31.01
PB Ratio:	2.11
Industry P/E:	-
Debt to Equity:	-

ROE:	6.79
EPS (TTM):	1.19
Book Value:	0.00
Face Value:	10.00

Beryl Drugs Ltd operates in the production, distribution, and export of branded and generic pharmaceutical formulations both domestically in India and internationally. Its product range includes I.V. fluids, small and large volume injectables, eye/ear drops, veterinary products, and injections. Sales are conducted through its established sales and distribution channels. The company also provides research and development services along with contract manufacturing. Based in Indore, India, Beryl Drugs Ltd was established as a public limited company on August 24, 1993, taking over the business operations of M/s Flora and Fauna Remedies on December 15, 1993. Its shares are listed on M.P. Stock Exchange, Bombay Stock Exchange, and Ahmedabad Stock Exchange. Beryl Drugs Ltd has expanded into a global presence in pharmaceutical manufacturing, research and development, contract manufacturing, and veterinary products. Its manufacturing facilities adhere to WHO GMP specifications, and it owns various brands such as BERI-CEF injection, F-Neuron, Amplicillin INJ, P-Mol, Biprox, B-Flox, among others. The company has been certified with ISO 9001:2000 for its quality management system.

Company name	Listing date	Industry	BSE symbol
BERYL DRUGS LTD.	Sep, 1994	Pharmaceuticals	BERLDRG

Shareholding pattern

Sep, 2023 Jun, 2023 Jan, 1970

Promoters

26.38%
Public

73.62%
Shares held by Employee Trusts

--%
Promoters

26.38%
Public

73.62%
Shares held by Employee Trusts

--%
Promoters

26.38%
Public

73.62%
Shares held by Employee Trusts

--%

Promoters
	26.38%

Public
	73.62%

Shares held by Employee Trusts
	--%

Promoters
	26.38%

Public
	73.62%

Shares held by Employee Trusts
	--%

Promoters
	26.38%

Public
	73.62%

Shares held by Employee Trusts
	--%

BERYL DRUGS LTD. FAQ's

What is the range of today's stock performance for BERYL DRUGS LTD.?

The stock performance today ranged from a low of 35.51 to a high of 37.07.

What are the 52-week low and high values for BERYL DRUGS LTD.?

The 52-week low is 19.35 (on 13-Nov-2023), and the 52-week high is 45.00 (on 09-Sep-2024).

What was the opening and previous closing prices for BERYL DRUGS LTD.?

The stock opened at 37.05 and closed at 37.05.

What are the upper and lower circuit limits for BERYL DRUGS LTD.?

The upper circuit limit is 23.93, and the lower circuit limit is 23.01.

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for BERYL DRUGS LTD.?

ROE is 6.79, EPS is 1.19, book value is not available

Search

Navigation section